carlobifulco Profile
carlobifulco

@carlobifulco

Followers
147
Following
533
Media
2
Statuses
487

iPhone: 45.329720,-121.712570
Joined September 2008
Don't wanna be here? Send us removal request.
@carlobifulco
carlobifulco
7 months
RT @AI4Pathology: For the past 5 years, our CLAM toolbox has been widely used by the community for whole-slide image (WSI) processing. For….
0
26
0
@carlobifulco
carlobifulco
9 months
RT @DrJasPlummer: Can’t wait to get my #multiomics2024 swag!!! If you haven’t registered you are missing out… all the fun #singlecell #spat….
0
5
0
@carlobifulco
carlobifulco
10 months
RT @aruthak: Don't miss out on from December 1-3! Join over 50 top industry and academic experts as they share grou….
0
3
0
@carlobifulco
carlobifulco
1 year
RT @sitcancer: Don't miss the 2024 Multi-omics Meeting Dec. 1–3 in QLD, Australia! Engage with global researchers and understand digital pa….
0
1
0
@carlobifulco
carlobifulco
1 year
RT @sitcancer: Discover how multi-omics is revolutionizing disease biology! Join the 2024 Multi-omics Meeting Dec. 1–3 in QLD, Australia an….
0
3
0
@carlobifulco
carlobifulco
2 years
RT @rbryanbell: FDA Approves 1st Cellular Therapy to Treat Patients w Metastatic Melanoma. Testament to the vision of Dr. Steven Rosenberg….
Tweet card summary image
fda.gov
The FDA approved Amtagvi, the first cellular therapy for the treatment of adults with unresectable or metastatic melanoma.
0
6
0
@carlobifulco
carlobifulco
2 years
RT @keegan_ke: Back at @ASCO, check out the @illumina abstracts.
Tweet media one
0
2
0
@carlobifulco
carlobifulco
2 years
0
6
0
@carlobifulco
carlobifulco
2 years
RT @JimMansfieldYWG: This is going to be an excellent meeting!.
0
2
0
@carlobifulco
carlobifulco
3 years
RT @BernardAFox: 💥 GREAT START TO FRIDAY! Dr Brian Piening of @LabPiening @ChilesResearch @ProvHealth is presenting @ EACRI Lab Mtg on “Mul….
0
3
0
@carlobifulco
carlobifulco
3 years
RT @BernardAFox: @LabPiening @alexadowdell 💥At #AMP22 ? checkout what @LabPiening Gurus & collaborators @carlobifulco @romleidner @WalterUr….
0
3
0
@carlobifulco
carlobifulco
3 years
RT @rbryanbell: Another huge win for Neoadjuvant immunotherapy: relatlimab + nivolumab in melanoma. The combo resulted in pCR=57%; OPR=70%.….
Tweet card summary image
nature.com
Nature - Patients with resectable clinical stage III or oligometastatic stage IV melanoma were given neoadjuvant relatlimab and nivolumab combination immunotherapy, which induced a high pathologic...
0
1
0
@carlobifulco
carlobifulco
3 years
RT @EricTopol: Towards drugging the undraggable in cancer: progress is being made vs KRAS, mutated in 1/4 cancers, but we're not there yet….
0
57
0
@carlobifulco
carlobifulco
3 years
RT @AI4Pathology: Excited to share our @Cancer_Cell review on #AI-driven multimodal data integration in #oncology. We discuss methods, and….
0
149
0
@carlobifulco
carlobifulco
3 years
RT @BernardAFox: Dr. Luigi Nezi @ istituto europeo di oncologica in Milan / Whirlwind intro to #microbiota / Brilliant work! / @NIBITSIENA….
0
2
0
@carlobifulco
carlobifulco
3 years
RT @PhilFebboMD_CMO: It’s critical that #cancer patients have access to #BioMarkerTesting. These are validated tests with proven clinical u….
0
8
0
@carlobifulco
carlobifulco
3 years
RT @ialhusseini: @#Human genome sequencing now costs less than $240. That work cost $100 million just 21 years ago. @illumina.
0
2
0